BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12510718)

  • 1. Hyperhomocysteinemia and retinal vascular occlusive disease.
    Abu El-Asrar AM; Abdel Gader AG; Al-Amro SA; Al-Attas OS
    Eur J Ophthalmol; 2002; 12(6):495-500. PubMed ID: 12510718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion.
    Vine AK
    Am J Ophthalmol; 2000 May; 129(5):640-4. PubMed ID: 10844057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia and retinal vascular occlusive disease.
    Battaglia Parodi M; Di Crecchio L
    Eur J Ophthalmol; 2003 Jun; 13(5):500; author reply 500-1. PubMed ID: 12841576
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.
    Vine AK
    Trans Am Ophthalmol Soc; 2000; 98():493-503. PubMed ID: 11190038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and central retinal vein occlusion in Iranian population.
    Moghimi S; Najmi Z; Faghihi H; Karkhaneh R; Farahvash MS; Maghsoudipour M
    Int Ophthalmol; 2008 Feb; 28(1):23-8. PubMed ID: 17636432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
    Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
    Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hyperhomocystinemia in retinal vascular occlusive disease.
    Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammi C; Occhiuto A; Lombardo VT
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):104-7. PubMed ID: 17164500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia: a risk factor for retinal vein occlusion.
    Yildirim C; Yaylali V; Tatlipinar S; Kaptanoğlu B; Akpinar S
    Ophthalmologica; 2004; 218(2):102-6. PubMed ID: 15004498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.
    Gao W; Wang YS; Zhang P; Wang HY
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1246-9. PubMed ID: 16538453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma total homocysteine and retinal vascular disease.
    Martin SC; Rauz S; Marr JE; Martin N; Jones AF; Dodson PM
    Eye (Lond); 2000 Aug; 14 ( Pt 4)():590-3. PubMed ID: 11040905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease.
    Cahill M; Karabatzaki M; Meleady R; Refsum H; Ueland P; Shields D; Mooney D; Graham I
    Br J Ophthalmol; 2000 Feb; 84(2):154-7. PubMed ID: 10655190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.
    Cahill MT; Stinnett SS; Fekrat S
    Am J Ophthalmol; 2003 Dec; 136(6):1136-50. PubMed ID: 14644226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branch retinal artery occlusion and non-ischemic central retinal vein occlusion due to hyperhomocysteinemia in a 14-year-old child.
    Rosenbaum PS; Srinivasan S; Zelefsky JR; Mayers M; Moradi IE
    J Pediatr Ophthalmol Strabismus; 2010 Jul; 47 Online():e1-4. PubMed ID: 21158360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine: a risk factor for retinal venous occlusive disease.
    Brown BA; Marx JL; Ward TP; Hollifield RD; Dick JS; Brozetti JJ; Howard RS; Thach AB
    Ophthalmology; 2002 Feb; 109(2):287-90. PubMed ID: 11825810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of branch retinal artery occlusion in a teenager due to hyperhomocysteinaemia; the interplay of genetic and nutritional defects.
    Shute C
    BMC Ophthalmol; 2018 Sep; 18(Suppl 1):220. PubMed ID: 30255822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and retinal vein occlusion: a population-based study.
    Chua B; Kifley A; Wong TY; Mitchell P
    Am J Ophthalmol; 2005 Jan; 139(1):181-2. PubMed ID: 15652845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia in central retinal vein occlusion in young adults.
    Parodi MB; Di Crecchio L
    Semin Ophthalmol; 2003 Sep; 18(3):154-9. PubMed ID: 15513477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.